MAP BioPharma is running a series of Patient Access Webinars. Our aim is to provide you with timely information and insight to help your Market Access planning. We will help you navigate uncertain times and offer thought leadership on key patient access topics.
Whilst many Market Access teams are working remotely, these lunchtime sessions will be an opportunity to quiz our team of experts. Sign up is completely free.
To register your interest, click on the Register Now button and complete the form. You will then receive log in details. If you are unable to join the live Webinar, please still register and we will forward the recording afterwards.
Please note these webinars are available for BioPharma and MedTech companies.
We are currently planning our next series of Patient Access Webinars which will be added shortly.
If there is a topic you would like us to cover in the future please get in touch via email on email@example.com. In the meantime enjoy the recordings of our sessions so far.
Tuesday 7th September 2021
12:30 – 13:30 BST
This final session of our conference, chaired by Steve Beard, Chief Consulting Officer who was joined by industry experts tackled the following topics: VPAS – what you need to know, commercial and managed access in England. This session concluded with a talk from Christian Hill, Chief Executive Officer, and co-founder of MAP, on ATMPs and responding to the new high cost / high value drugs.
Steve Beard, Chief Consulting Officer introduced an impressive array of speakers from NHS, NICE and EMIG who discussed; optional and approaches to utilising Real World Evidence lined datasets, the NHS Long Term Plan and what this means for pharma companies and the continued development of digital systems and technology in finding new levels of patient value.Learn more
The MAP Policy and Public Affairs team consider how the current and future policy landscape will impact on the market access function for innovative medicines, and host an insightful panel discussion with rare disease patient organisation and industry representatives. Panellists reflected on the potential for the NICE methods review, proposed Innovative Medicines Fund and other policy levers to improve access to orphan medicine arrangements.
Dr Grace Jennings chaired this opening session introducing a range of experts addressing the following topics: the importance of patient engagement throughout the HTA process, using patient registries in HTAs and future development for patient access in new health technologies.Learn more
A panel discussion addressing the impact of the EU HTA on companies as of 2024.Learn more
In this webinar we were joined by Dr Grace Jennings, Head of Map Online and her team who took us through the different healthcare landscapes around the world including, Ireland and the Benelux countries. The team also shared insights from two resent projects which included a study of multiple indication pricing and Innovation Licensing and Access Pathways (ILAP).Learn more
In this webinar, we were delighted to be joined by a panel of experts who discussed the challenges facing patients with rare diseases and considering solutions.Learn more
The first in our international series, focused on different healthcare landscapes around the world starting with the US.Learn more
In this webinar we outlined the differences and similarities in the reimbursement process across the UK via the nation-specific bodies such as NICE, AWMSG and SMC.Learn more
In this webinar, we are delighted to be joined by Dr Alexander Natz, Secretary General of EUCOPE, Diane Kleinermans, Advisor to the Ministry of Health and Social Affairs Belgium and Francis Arickx, Advisor at RIZIV-INAMI who will help you understand the opportunities to engage in BeNeLuxA.Learn more
In this webinar, our Market Access experts detailed the factors that influence pharmaceutical prices and provided an example of a model that has helped MAP clients to plan and respond to senior management questions.Learn more
In this webinar, Christian Hill, CEO of MAP BioPharma, provided an overview on how to accelerate patient access by reducing delays in horizon scanning. He also considered how to influence the process so you can improve the likelihood of a favourable outcome for your company.Learn more
In this webinar, Christian Hill CEO of MAP BioPharma was joined by Dr. Alexander Natz, Secretary General of EUCOPE and they discussed the challenges the industry is facing and identified potential solutions.
Copyright © 2021.
MAP BioPharma Limited.
All rights reserved.
MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
MAP BioPharma Limited is a registered company in England and Wales.
Company Registration Number 08209281
VAT Group Registration Number:
GB 292 8576 52